Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalbavancin vs Vancomycin for Catheter-Related Bloodstream Infections
NCT00057369Phase 2Unknown
- Sponsor
- Vicuron Pharmaceuticals
- Start
- Feb 2001
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalbavancin in catheter-related bloodstream infection (CRBSI), sponsored by Vicuron Pharmaceuticals. Status: unknown.
02
Drugs
dalbavancin
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT00057369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057369.